Covered recipient · General Payments record
STEVEN MIRABELLA
General Payments · PY2022–2024
$1,150.02
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $585.17 | 6 |
| Education | $271.39 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $457.30 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $131.25 | 1 |
| Acerta Pharma LLC | $125.00 | 1 |
| Lexicon Pharmaceuticals, Inc. | $124.99 | 1 |
| Merck Sharp & Dohme Corporation | $18.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $163.62 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1122121156 | CMS |
| Abbott Laboratories | $271.39 | 05/24/2024 | Education | Undisputed | 01/23/2026 | 1122131838 | CMS |
| Abbott Laboratories | $22.29 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1122123852 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110514138 | CMS |
| Boston Scientific Corporation | $131.25 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092482625 | CMS |
| Lexicon Pharmaceuticals, Inc. | $124.99 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081717978 | CMS |
| Merck Sharp & Dohme LLC | $18.02 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141936141 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.